Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela

Introduction: The treatment of urinary tract infections has become more challenging due to the increasing frequency of multidrug-resistant Escherichia coli in human populations. Objective: To characterize multidrug-resistant E. coli isolates causing community-acquired urinary tract infections in Cum...

Full description

Bibliographic Details
Published in:Biomédica
Main Authors: Militza Guzmán, Elsa Salazar, Vicmaris Cordero, Ana Castro, Andreína Villanueva, Hectorina Rodulfo, Marcos De Donato
Format: Article in Journal/Newspaper
Language:English
Spanish
Published: Instituto Nacional de Salud 2019
Subjects:
R
Online Access:https://doi.org/10.7705/biomedica.v39i2.4030
https://doaj.org/article/375ff93a78a340eba1bacf2a80d21407
id ftdoajarticles:oai:doaj.org/article:375ff93a78a340eba1bacf2a80d21407
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:375ff93a78a340eba1bacf2a80d21407 2023-05-15T15:12:10+02:00 Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela Militza Guzmán Elsa Salazar Vicmaris Cordero Ana Castro Andreína Villanueva Hectorina Rodulfo Marcos De Donato 2019-05-01T00:00:00Z https://doi.org/10.7705/biomedica.v39i2.4030 https://doaj.org/article/375ff93a78a340eba1bacf2a80d21407 EN ES eng spa Instituto Nacional de Salud https://www.revistabiomedica.org/index.php/biomedica/article/view/4030 https://doaj.org/toc/0120-4157 0120-4157 doi:10.7705/biomedica.v39i2.4030 https://doaj.org/article/375ff93a78a340eba1bacf2a80d21407 Biomédica: revista del Instituto Nacional de Salud, Vol 39, Pp 96-107 (2019) Escherichia coli urologic diseases beta-lactamases drug resistance bacterial community-acquired infections Medicine R Arctic medicine. Tropical medicine RC955-962 article 2019 ftdoajarticles https://doi.org/10.7705/biomedica.v39i2.4030 2022-12-31T00:47:17Z Introduction: The treatment of urinary tract infections has become more challenging due to the increasing frequency of multidrug-resistant Escherichia coli in human populations. Objective: To characterize multidrug-resistant E. coli isolates causing community-acquired urinary tract infections in Cumaná, Venezuela, and associate possible risk factors for infection by extended-spectrum beta-lactamases (ESBL)-producing isolates. Materials and methods: We included all the patients with urinary tract infections attending the urology outpatient consultation and emergency unit in the Hospital de Cumaná, Estado Sucre, Venezuela, from January through June, 2014. blaTEM, blaSHV and blaCTX-M genes detection was carried out by PCR. Results: We found a high prevalence of multidrug-resistant E. coli (25.2%) with 20.4% of the isolates producing ESBL. The ESBL-producing isolates showed a high frequency (66.7%) of simultaneous resistance to trimethoprim-sulphamethoxazole, fluoroquinolones and aminoglycosides compared to non-producing isolates (2.4%). Of the resistant isolates, 65.4% carried the blaTEM gene, 34.6% the blaCTX-M and 23.1% the blaSHV. The blaCTX-M genes detected belonged to the CTX-M-1 and CTX-M-2 groups. Plasmid transfer was demonstrated by in vitro conjugation in 17 of the 26 ESBL-producing isolates. All three genes detected were transferred to the transconjugants. Age over 60 years, complicated urinary tract infections and previous use of a catheter predisposed patients to infection by ESBL-producing E. coli. Conclusions: The high frequency of multidrug-resistant ESBL-producing isolates should alert the regional health authorities to take measures to reduce the risk of outbreaks caused by these types of bacteria in the community. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Biomédica 39 96 107
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
Spanish
topic Escherichia coli
urologic diseases
beta-lactamases
drug resistance
bacterial
community-acquired infections
Medicine
R
Arctic medicine. Tropical medicine
RC955-962
spellingShingle Escherichia coli
urologic diseases
beta-lactamases
drug resistance
bacterial
community-acquired infections
Medicine
R
Arctic medicine. Tropical medicine
RC955-962
Militza Guzmán
Elsa Salazar
Vicmaris Cordero
Ana Castro
Andreína Villanueva
Hectorina Rodulfo
Marcos De Donato
Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela
topic_facet Escherichia coli
urologic diseases
beta-lactamases
drug resistance
bacterial
community-acquired infections
Medicine
R
Arctic medicine. Tropical medicine
RC955-962
description Introduction: The treatment of urinary tract infections has become more challenging due to the increasing frequency of multidrug-resistant Escherichia coli in human populations. Objective: To characterize multidrug-resistant E. coli isolates causing community-acquired urinary tract infections in Cumaná, Venezuela, and associate possible risk factors for infection by extended-spectrum beta-lactamases (ESBL)-producing isolates. Materials and methods: We included all the patients with urinary tract infections attending the urology outpatient consultation and emergency unit in the Hospital de Cumaná, Estado Sucre, Venezuela, from January through June, 2014. blaTEM, blaSHV and blaCTX-M genes detection was carried out by PCR. Results: We found a high prevalence of multidrug-resistant E. coli (25.2%) with 20.4% of the isolates producing ESBL. The ESBL-producing isolates showed a high frequency (66.7%) of simultaneous resistance to trimethoprim-sulphamethoxazole, fluoroquinolones and aminoglycosides compared to non-producing isolates (2.4%). Of the resistant isolates, 65.4% carried the blaTEM gene, 34.6% the blaCTX-M and 23.1% the blaSHV. The blaCTX-M genes detected belonged to the CTX-M-1 and CTX-M-2 groups. Plasmid transfer was demonstrated by in vitro conjugation in 17 of the 26 ESBL-producing isolates. All three genes detected were transferred to the transconjugants. Age over 60 years, complicated urinary tract infections and previous use of a catheter predisposed patients to infection by ESBL-producing E. coli. Conclusions: The high frequency of multidrug-resistant ESBL-producing isolates should alert the regional health authorities to take measures to reduce the risk of outbreaks caused by these types of bacteria in the community.
format Article in Journal/Newspaper
author Militza Guzmán
Elsa Salazar
Vicmaris Cordero
Ana Castro
Andreína Villanueva
Hectorina Rodulfo
Marcos De Donato
author_facet Militza Guzmán
Elsa Salazar
Vicmaris Cordero
Ana Castro
Andreína Villanueva
Hectorina Rodulfo
Marcos De Donato
author_sort Militza Guzmán
title Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela
title_short Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela
title_full Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela
title_fullStr Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela
title_full_unstemmed Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela
title_sort multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by escherichia coli in venezuela
publisher Instituto Nacional de Salud
publishDate 2019
url https://doi.org/10.7705/biomedica.v39i2.4030
https://doaj.org/article/375ff93a78a340eba1bacf2a80d21407
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Biomédica: revista del Instituto Nacional de Salud, Vol 39, Pp 96-107 (2019)
op_relation https://www.revistabiomedica.org/index.php/biomedica/article/view/4030
https://doaj.org/toc/0120-4157
0120-4157
doi:10.7705/biomedica.v39i2.4030
https://doaj.org/article/375ff93a78a340eba1bacf2a80d21407
op_doi https://doi.org/10.7705/biomedica.v39i2.4030
container_title Biomédica
container_volume 39
container_start_page 96
op_container_end_page 107
_version_ 1766342892510511104